THE EMERGING ROLE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS

Descargar Publicación
Nuevas moléculas del IOCB de Praga reducen el apetito y protegen el cerebro contra enfermedades de tipo Alzheimer Update on Obesity and Cardiovascular Risk: From Pathophysiology to Clinical Management